| Model Number |
TV-AB2680-N |
| Medical Device Problem Code |
Lack of Effect (4065)
|
| Health Effect - Clinical Codes |
Aneurysm (1708); Clinical Endoleak (4843)
|
| Date of Event |
05/10/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, follow-up report will be submitted.H3 other text : device remains implanted.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an abdominal aortic aneurysm (aaa) on (b)(6) 2022 with the implant of an alto abdominal stent graft system.Routine follow-up conducted on (b)(6) 2024 identified a type 1a endoleak and aneurysm enlargement signified by sac growth of 1.5 cm.The physician is planning a secondary intervention with a palmaz (non-endologix) stent, however secondary has not been scheduled at this time.The patient is currently being monitored.
|
| |
|
Additional Manufacturer Narrative
|
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix found the type ia endoleak, sac growth of 18.5mm and additional endovascular procedure (per product use report) complaints are confirmed.This is consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of this complaint cannot be determined.Procedure related harms could not be determined.The final patient status remains unknown.The final patient status was not made available to endologix.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: g3: awareness date - updated.H6: health effect - impact code: remove code 4614.H6 investigation finding codes ¿ remove code 3233.H6 investigation conclusion codes ¿ remove code 11.
|
| |
|
Search Alerts/Recalls
|